| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |